TiLOOP® Bra MPX
The titanised mesh TiLOOP® Bra MPX fixes the subcutaneously dissected corpus mammae in a mastopexy, symmetrical alignment or reduction surgery.
Complete portfolio The TiLOOP® Bra product family covers all indications for breast surgery with tissue reinforcing material.
TiLOOP® Bra Pocket ▸ Pre-pectoral reconstruction/augmentation
TiLOOP® Bra ▸ Sub-pectoral reconstruction/augmentation
TiLOOP® Bra MPX ▸ Mastopexy/reduction surgery/symmetrical alignment
Optimal capsule quality Compared to simple polypropylene, the hydrophilic and titanised surface carries a reduced risk of inflammation 1 and thus a reduced tendency towards the formation of connective tissue-like scars and shrinkage: combined with minimal weight and ides the ideal conditions for a permanent, stable result as well as both desirable tissue ingrowth and a vascularied, flexible, and therefore optimum capsule quality.
Customisable TiLOOP® Bra MPX is cut at the 12 o’clock position and is available in three sizes. The titanised mesh can be ideally adapted to fit the size and shape of the breast, thus providing the desired long-term lifting effect.
- Titanised Type 1a polypropylene mesh
- Weight: 16 g/m2
- Pore size: 1.0 mm
- Monofilament fabric
- Atraumatic, laser-cut edges
- EO-sterilised (ethylene oxide), pyrogen free
|Size||a (Height)||b (Weight)||c (Hole Ø)|
|Small||20.0 cm||17.0 cm||5.0 cm|
|Medium||22.0 cm||21.5 cm||5.5 cm|
|Large||25.0 cm||26.0 cm||6.0 cm|
In mastopexy, symmetrical alignment or reduction surgery, the titanised TiLOOP® Bra MPX mesh implant fixes the subcutaneously dissected corpus mammae.
The cut at the 12 o’clock position enables the flat TiLOOP® Bra MPX to be easily shaped into a three-dimensional form without wringles.
One of the determining factors for successful breast surgery in the long term, is the correct decision for or against the use of tissue reinforcing material (synthetic mesh or ADM).
TiLOOP® Bra mesh implants* are made of Type 1a polypropylene mesh (macroporous, light & monofilament) with a titanised, hydrophilic surface. Compared to simple polypropylene, this offers a number of advantages, which are already known in the use of titanised mesh implants for hernia surgery, such as:
*TiLOOP® Bra mesh implants are not a tissue replacement.
90449 Nürnberg, Germany
1 Scheidbach et al. In vivo studies comparing the biocompatibility of various polypropylene meshes and their handling properties during endoscopic total extraperitoneal (TEP) patchplasty. Surg Endosc (2004) 18: 211–220
2 Lehle K., Lohn S. Verbesserung des Langzeitverhaltens von Implantaten und anderen Biomaterialien auf Kunststoffbasis durch plasmaaktivierte Gasphasenabscheidung (PACVD), Abschlussbericht Forschungsverbund “Biomaterialien (FORBIOMAT II)”, 149–173, 2002
3 Scheidbach et al. Influence of Titanium Coating on the Biocompatibility of a Heavyweight Polypropylene Mesh. Eur Surg Res (2004) 36: 313–317
4 Casella et al. TiLoop® Bra mesh used for immediate breast reconstruction: comparison of retropectoral and subcutaneous implant placement in a prospective single-institution series. Eur J Plast Surg (2014) 37 (11): 599-604
5 Bernini et al. Subcutaneous Direct-to-Implant Breast Reconstruction: Surgical, Functional, and Aesthetic Results after Long-Term Follow-Up. Plast Reconstr Surg Glob Open (2016) 3 (12):e574
6 Casella et al. Subcutaneous Tissue Expander Placement with Synthetic Titanium-Coated Mesh in Breast Reconstruction: Long-term Results. Plast Reconstr Surg Glob Open (2016) 3 (12):e577
7 Gschwantler-Kaulich et al. Mesh versus acellular dermal matrix in immediate implant based breast reconstruction - A prospective randomized trial. EJSO (2016) 42(5): 665–671
8 Rezai et al. Risk-reducing, conservative mastectomy - analysis of surgical outcome and quality of life in 272 implant-based reconstructions using TiLoop® Bra versus autologous corial flaps. Gland Surgery (2015) 5(1): 1–8
9 Dieterich et al. Implant-based breast reconstruction using a titanium-coated polypropylene mesh (TiLOOP Bra): a multicenter study of 231 cases. Plast Reconstr Surg (2013) 132(1): 8e-19e